First Time Loading...

Vir Biotechnology Inc
NASDAQ:VIR

Watchlist Manager
Vir Biotechnology Inc Logo
Vir Biotechnology Inc
NASDAQ:VIR
Watchlist
Price: 7.63 USD -5.1% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

VIR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. [ Read More ]

The intrinsic value of one VIR stock under the Base Case scenario is 3.45 USD. Compared to the current market price of 7.63 USD, Vir Biotechnology Inc is Overvalued by 55%.

Key Points:
VIR Intrinsic Value
Base Case
3.45 USD
Overvaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Vir Biotechnology Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling VIR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Vir Biotechnology Inc

Provide an overview of the primary business activities
of Vir Biotechnology Inc.

What unique competitive advantages
does Vir Biotechnology Inc hold over its rivals?

What risks and challenges
does Vir Biotechnology Inc face in the near future?

Has there been any significant insider trading activity
in Vir Biotechnology Inc recently?

Summarize the latest earnings call
of Vir Biotechnology Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vir Biotechnology Inc.

Provide P/S
for Vir Biotechnology Inc.

Provide P/E
for Vir Biotechnology Inc.

Provide P/OCF
for Vir Biotechnology Inc.

Provide P/FCFE
for Vir Biotechnology Inc.

Provide P/B
for Vir Biotechnology Inc.

Provide EV/S
for Vir Biotechnology Inc.

Provide EV/GP
for Vir Biotechnology Inc.

Provide EV/EBITDA
for Vir Biotechnology Inc.

Provide EV/EBIT
for Vir Biotechnology Inc.

Provide EV/OCF
for Vir Biotechnology Inc.

Provide EV/FCFF
for Vir Biotechnology Inc.

Provide EV/IC
for Vir Biotechnology Inc.

Show me price targets
for Vir Biotechnology Inc made by professional analysts.

What are the Revenue projections
for Vir Biotechnology Inc?

How accurate were the past Revenue estimates
for Vir Biotechnology Inc?

What are the Net Income projections
for Vir Biotechnology Inc?

How accurate were the past Net Income estimates
for Vir Biotechnology Inc?

What are the EPS projections
for Vir Biotechnology Inc?

How accurate were the past EPS estimates
for Vir Biotechnology Inc?

What are the EBIT projections
for Vir Biotechnology Inc?

How accurate were the past EBIT estimates
for Vir Biotechnology Inc?

Compare the revenue forecasts
for Vir Biotechnology Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vir Biotechnology Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vir Biotechnology Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vir Biotechnology Inc compared to its peers.

Compare the P/E ratios
of Vir Biotechnology Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Vir Biotechnology Inc with its peers.

Analyze the financial leverage
of Vir Biotechnology Inc compared to its main competitors.

Show all profitability ratios
for Vir Biotechnology Inc.

Provide ROE
for Vir Biotechnology Inc.

Provide ROA
for Vir Biotechnology Inc.

Provide ROIC
for Vir Biotechnology Inc.

Provide ROCE
for Vir Biotechnology Inc.

Provide Gross Margin
for Vir Biotechnology Inc.

Provide Operating Margin
for Vir Biotechnology Inc.

Provide Net Margin
for Vir Biotechnology Inc.

Provide FCF Margin
for Vir Biotechnology Inc.

Show all solvency ratios
for Vir Biotechnology Inc.

Provide D/E Ratio
for Vir Biotechnology Inc.

Provide D/A Ratio
for Vir Biotechnology Inc.

Provide Interest Coverage Ratio
for Vir Biotechnology Inc.

Provide Altman Z-Score Ratio
for Vir Biotechnology Inc.

Provide Quick Ratio
for Vir Biotechnology Inc.

Provide Current Ratio
for Vir Biotechnology Inc.

Provide Cash Ratio
for Vir Biotechnology Inc.

What is the historical Revenue growth
over the last 5 years for Vir Biotechnology Inc?

What is the historical Net Income growth
over the last 5 years for Vir Biotechnology Inc?

What is the current Free Cash Flow
of Vir Biotechnology Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vir Biotechnology Inc.

Financials

Balance Sheet Decomposition
Vir Biotechnology Inc

Current Assets 1.6B
Cash & Short-Term Investments 1.5B
Other Current Assets 65.8m
Non-Current Assets 330.8m
Long-Term Investments 105.3m
PP&E 167.2m
Intangibles 39.5m
Other Non-Current Assets 18.9m
Current Liabilities 175.4m
Accounts Payable 6.3m
Accrued Liabilities 104.2m
Other Current Liabilities 64.9m
Non-Current Liabilities 153.4m
Other Non-Current Liabilities 153.4m
Efficiency

Earnings Waterfall
Vir Biotechnology Inc

Revenue
86.2m USD
Cost of Revenue
-2.8m USD
Gross Profit
83.4m USD
Operating Expenses
-767.7m USD
Operating Income
-684.3m USD
Other Expenses
69.2m USD
Net Income
-615.1m USD

Free Cash Flow Analysis
Vir Biotechnology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

VIR Profitability Score
Profitability Due Diligence

Vir Biotechnology Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive 3-Years Revenue Growth
Negative Revenue Growth Forecast
29/100
Profitability
Score

Vir Biotechnology Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

VIR Solvency Score
Solvency Due Diligence

Vir Biotechnology Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
65/100
Solvency
Score

Vir Biotechnology Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VIR Price Targets Summary
Vir Biotechnology Inc

Wall Street analysts forecast VIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VIR is 32.93 USD with a low forecast of 12.12 USD and a high forecast of 115.5 USD.

Lowest
Price Target
12.12 USD
59% Upside
Average
Price Target
32.93 USD
332% Upside
Highest
Price Target
115.5 USD
1 414% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

VIR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

VIR Price
Vir Biotechnology Inc

1M 1M
-23%
6M 6M
-6%
1Y 1Y
-69%
3Y 3Y
-85%
5Y 5Y
-46%
10Y 10Y
-46%
Annual Price Range
7.63
52w Low
7.63
52w High
27.29
Price Metrics
Average Annual Return 29.34%
Standard Deviation of Annual Returns 70.14%
Max Drawdown -91%
Shares Statistics
Market Capitalization 1B USD
Shares Outstanding 135 032 000
Percentage of Shares Shorted 6.17%

VIR Return Decomposition
Main factors of price return

What is price return decomposition?

VIR News

Other Videos

Last Important Events
Vir Biotechnology Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Vir Biotechnology Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Vir Biotechnology Inc Logo
Vir Biotechnology Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1B USD

Dividend Yield

0%

Description

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California and currently employs 444 full-time employees. The company went IPO on 2019-10-11. The company has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The firm's pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus (HBV), influenza A virus, and human immunodeficiency virus (HIV). Its product candidates include Sotrovimab and VIR-7832, VIR-2218, VIR-3434, VIR-2482, VIR-1111. The company is engaged in developing differentiated monoclonal antibodies (mAbs) as well as vaccines and small molecules that focuses is on treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VIR-2218 and VIR-3434, are for the treatment of HBV. VIR-2482 is an investigational IM administered influenza A-neutralizing mAb.

Contact

CALIFORNIA
San Francisco
499 Illinois St Ste 500
+14159064324.0
https://www.vir.bio/

IPO

2019-10-11

Employees

444

Officers

Executive VP & Chief Technology Officer
Dr. Ann M. Hanly Ph.D.
Executive VP & Chief Medical Officer
Dr. Phillip Pang M.D., Ph.D.
CEO & Director
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Co-Founder & Scientific Advisor
Dr. Louis J. Picker M.D.
Executive VP & CFO
Mr. Sung H. Lee
Executive VP & Chief Scientific Officer
Dr. Jennifer Eileen Towne Ph.D.
Show More
Vice President of Investor Relations
Ms. Heather Rowe Armstrong
Executive VP, General Counsel & Corporate Secretary
Ms. Vanina De Verneuil J.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one VIR stock?

The intrinsic value of one VIR stock under the Base Case scenario is 3.45 USD.

Is VIR stock undervalued or overvalued?

Compared to the current market price of 7.63 USD, Vir Biotechnology Inc is Overvalued by 55%.